| 1 |
Chinese Society of Respiratory Diseases. Chinese Adult Community-Acquired Pneumonia Diagnosis and Treatment Guidelines (2016 edition). Chin J Tuberculosis and Respir. 2016; 39(4):253-79.
|
| 2 |
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-13.
doi: 10.1016/S0140-6736(20)30211-7
pmid: 32007143
|
| 3 |
Damas P, Frippiat F, Ancion A, Canivet JL, Lambermont B, Layios N, et al. Prevention of ventilator-associated pneumonia and ventilator-associated conditions: a randomized controlled trial with subglottic secretion suctioning. Crit Care Med. 2015; 43(1):22-30.
doi: 10.1097/CCM.0000000000000674
pmid: 25343570
|
| 4 |
Centers for Disease Control and Prevention (CDC). Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep. 1999; 48(32):707-10.
pmid: 21033181
|
| 5 |
Mediavilla JR, Chen L, Mathema B, Kreiswirth BN. Global epidemiology of community-associated methicillin-resistant Staphylococcus aureus(CA-MRSA). Curr Opin Microbiol. 2012; 15(5):588-95.
doi: 10.1016/j.mib.2012.08.003
pmid: 23044073
|
| 6 |
Obed M, García-Vidal C, Pessacq P, Mykietiuk A, Viasus D, Cazzola L, et al. Clinical features and outcome of community-acquired methicillin-resistant Staphylococcus aureus pneumonia. Enferm Infecc Microbiol Clin. 2014; 32(1):23-7.
pmid: 23473825
|
| 7 |
Hetem DJ, Westh H, Boye K, Jarløv JO, Bonten MJ, Bootsma MC. Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus in Danish Hospitals. J Antimicrob Chemother. 2012; 67(7):1775-80.
doi: 10.1093/jac/dks125
pmid: 22523315
|
| 8 |
Kashiwada T, Kikuchi K, Abe S, Kato H, Hayashi H, Morimoto T, et al, Staphylococcal enterotoxin B toxic shock syndrome induced by community-acquired methicillin-resistant Staphylococcus aureus(CA-MRSA). Intern Med. 2012; 51(21):3085-8.
doi: 10.2169/internalmedicine.51.7295
pmid: 23124156
|
| 9 |
Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. J Hosp Infect. 2011; 79(3):189-93.
doi: 10.1016/j.jhin.2011.04.028
pmid: 21741111
|
| 10 |
Chen CJ, Unger C, Hoffmann W, Lindsay JA, Huang YC, Friedrich Götz F. Characterization and comparison of 2 distinct epidemic community-associated methicillin-resistant Staphylococcus aureus clones of ST59 lineage. PLoS One. 2013; 8(9):e63210.
doi: 10.1371/journal.pone.0063210
pmid: 24039691
|
| 11 |
Bao WP, Guo HY, Chen YQ, Zhou X. A case of community-acquired methicillin-resistant Staphylococcus aureus necrotizing pneumonia with bloodstream infection. Chinese Journal of Respiratory and Critical Care Medicine. 2013; 12(1):89-91.
|
| 12 |
Silverman JA, Mortin LI, Vanpraagh AD, Li T, Alder J. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis. 2005; 191(12):2149-52.
doi: 10.1086/430352
pmid: 15898002
|
| 13 |
Carpenter CF, Chambers HF. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis. 2004; 38(7):994-1000.
doi: 10.1086/383472
pmid: 15034832
|
)
